Jopson, Laura

The inter-relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis

Dyson, J. K., Wilkinson, N., Jopson, L., Mells, G., Bathgate, A., Heneghan, M. A., Neuberger, J., Hirschfield, G. M., Ducker, S. J., The UK‐PBC Consortium, et al. (2016) · Alimentary Pharmacology & Therapeutics

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 78

Rituximab is ineffective for treatment of fatigue in primary biliary cholangitis: a phase 2 randomized controlled trial

Khanna, A., Jopson, L., Howel, D., Bryant, A., Blamire, A., Newton, J. L., & Jones, D. E. (2019) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 75

The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis

Barron‐Millar, B., Ogle, L., Mells, G., Flack, S., Badrock, J., Sandford, R., Kirby, J., Palmer, J., Jopson, L., Brain, J., et al. (2021) · Hepatology

Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms

Cited by 45

Early Molecular Stratification of High-risk Primary Biliary Cholangitis

Hardie, C., Green, K., Jopson, L., Millar, B., Innes, B., Pagan, S., Tiniakos, D., Dyson, J., Haniffa, M., Bigley, V., et al. (2016) · EBioMedicine

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 32

Quality of life in patients with primary biliary cholangitis: A cross-geographical comparison

Montali, L., Gragnano, A., Miglioretti, M., Frigerio, A., Vecchio, L., Gerussi, A., Cristoferi, L., Ronca, V., D’Amato, D., O’Donnell, S. E., et al. (2021) · Journal of Translational Autoimmunity

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 26

The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study

Jones, D. E. J., Wetten, A., Barron-Millar, B., Ogle, L., Mells, G., Flack, S., Sandford, R., Kirby, J., Palmer, J., Brotherston, S., et al. (2022) · eBioMedicine

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 22

Anti-Cholestatic Therapy with Obeticholic Acid Improves Short-Term Memory in Bile Duct-Ligated Mice

Gee, L. M. V., Barron-Millar, B., Leslie, J., Richardson, C., Zaki, M. Y. W., Luli, S., Burgoyne, R. A., Cameron, R. I. T., Smith, G. R., Brain, J. G., et al. (2023) · The American Journal of Pathology

Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms

Cited by 18

P1198 : Histological stage is relevant for risk-stratification in primary biliary cirrhosis

Carbone, M., Sharp, S. J., Heneghan, M. A., Neuberger, J. M., Hirschfield, G. M., Burroughs, A. K., Thorburn, D., Bathgate, A., Aldersley, M., Adgey, C., et al. (2015) · Journal of Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 15

Are Clinicians Ready for Safe Use of Stratified Therapy in Primary Biliary Cholangitis (PBC)? A Study of Educational Awareness

Jopson, L., Khanna, A., Peterson, P., Rudell, E., Corrigan, M., & Jones, D. (2018) · Digestive Diseases and Sciences

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 9